Fereidoun Abtin, MD
Dr. Fereidoun Abtin is a thoracic interventional radiologist at the UCLA Medical Center in Santa Monica, California. He specializes in interventions for cancers of the chest and has earned international respect as an expert in the minimally invasive treatment of lung cancer, malignant pleural mesothelioma, and thymoma.[1]
Dr. Abtin is skilled in lung biopsy and thermal ablation of primary and metastatic pulmonary tumors. His practice includes the use of radiofrequency ablation, microwave ablation, and cryoablation of thoracic tumors. He is a pioneer in the use of cryoablation for the treatment of malignant pleural mesothelioma.
Education and Career
Dr. Abtin earned his medical degree at Kasturba Medical College in India, which is where he also completed his internship and residency in Radiology. He later completed a fellowship with the Thoracic Radiology Research Group followed by another in Radiology at the UCLA School of Medicine.[1]
At UCLA, he is the director of the Thoracic Imaging Research Laboratory and the director of the Santa Monica Outpatient Center. While there, he has built a robust lung biopsy practice and tissue biobank.
Research
Dr. Abtin is internationally known for his research in the management of lung cancer and chest neoplasms, including mesothelioma and thymoma. He is highly regarded for the innovations that have resulted from his efforts. He is currently focusing on the use of non-surgical minimally invasive thermal ablation and cryoablation techniques in the management of thoracic cancers and is involved with the Computer Vision and Imaging Biomarkers group on multiple projects.[1]
His recent publications include:[2]
- Quantitative Computed Tomography Lung COVID Scores with Laboratory Markers: Utilization to Predict Rapid Progression and Monitor Longitudinal Changes in Patients with Coronavirus 2019 (COVID-19) Pneumonia. Biomedicines. 2024 Jan 06; 12(1). Kang DH, Kim GHJ, Park SB, Lee SI, Koh JS, Brown MS, Abtin F, McNitt-Gray MF, Goldin JG, Lee JS. PMID: 38255225; PMCID: PMC10813449.
- Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study. AJR Am J Roentgenol. 2023 Nov 15. Fintelmann FJ, Graur A, Oueidat K, Simon J, Harvey Barnes JM, McDermott S, Genshaft SJ, Healey TT, Suh RD, Maxwell AWP, Abtin F. PMID: 37966037.
- Pulmonary sarcoidosis: A comprehensive review: Past to present. J Autoimmun. 2023 Oct 19; 103107. Belperio JA, Fishbein MC, Abtin F, Channick J, Balasubramanian SA, Lynch Iii JP. PMID: 37865579.
- The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Cell Rep Med. 2023 10 17; 4(10):101198. Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, Escobedo AK, You DG, Castro CM, Im H, Kilic T, Garlin MA, Skog J, Dinulescu DM, Dudley J, Agrawal N, Cheng J, Abtin F, Aberle DR, Chia D, Elashoff D, Grognan T, Krysan K, Oh SS, Strom C, Tu M, Wei F, Xian RR, Skates SJ, Zhang DY, Trinh T, Watson M, Aft R, Rawal S, Agarwal A, Kesmodel SB, Yang C, Shen C, Hochberg FH, Wong DTW, Patel AA, Papadopoulos N, Bettegowda C, Cote RJ, Srivastava S, Lee H, Carter BS, Balaj L. PMID: 37716353; PMCID: PMC10591039.
- Changes in Lung Volumes with Spirometric Disease Progression in COPD. Chronic Obstr Pulm Dis. 2023 Jul 26; 10(3):270-285. Arjomandi M, Zeng S, Chen J, Bhatt SP, Abtin F, Barjaktarevic I, Barr RG, Bleecker ER, Buhr RG, Criner GJ, Comellas AP, Couper DJ, Curtis JL, Dransfield MT, Fortis S, Han MK, Hansel NN, Hoffman EA, Hokanson JE, Kaner RJ, Kanner RE, Krishnan JA, Labaki WW, Lynch DA, Ortega VE, Peters SP, Woodruff PG, Cooper CB, Bowler RP, Paine R, Rennard SI, Tashkin DP, and the COPDGene and SPIROMICS Investigators. PMID: 37199719; PMCID: PMC10484496.
- Transthoracic Needle Biopsy Is a Safe and Effective Diagnostic Procedure. J Am Coll Radiol. 2023 Jun 10. Maxwell AWP, Abtin F, Fintelmann FJ, Baird GL, Suh RD, Sofocleous CT, Solomon SB. PMID: 37302679.
- Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis. Expert Rev Anti Infect Ther. 2023 Jul-Dec; 21(7):723-736. Lynch JP, Fishbein MC, Abtin F, Zhanel GG. PMID: 37262298.
- How AI Responds to Common Lung Cancer Questions: ChatGPT vs Google Bard. Radiology. 2023 06; 307(5):e230922. Rahsepar AA, Tavakoli N, Kim GHJ, Hassani C, Abtin F, Bedayat A. PMID: 37310252.
- Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study. Lancet Digit Health. 2023 02; 5(2):e83-e92. Chaudhary MFA, Hoffman EA, Guo J, Comellas AP, Newell JD, Nagpal P, Fortis S, Christensen GE, Gerard SE, Pan Y, Wang D, Abtin F, Barjaktarevic IZ, Barr RG, Bhatt SP, Bodduluri S, Cooper CB, Gravens-Mueller L, Han MK, Kazerooni EA, Martinez FJ, Menchaca MG, Ortega VE, Iii RP, Schroeder JD, Woodruff PG, Reinhardt JM. PMID: 36707189; PMCID: PMC9896720.
- Treatment of Synchronous Primary Lung Cancer in Single Lung Patients. Cardiovasc Intervent Radiol. 2022 12; 45(12):1874-1876. Johnson S, Abtin F. PMID: 35986106.
